Medicine
Zyclara 0.25% cream
Zyclara 0.25% cream is a prescription medicine containing Imiquimod for topical use, marketed by Bausch Health, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Avoid freezing. Store at 25°C (77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Imiquimod
- Brand
- Zyclara
- Strength
- 0.25%
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 bottle
- Marketing authorisation holder
- Bausch Health
- Manufacturer
- Bausch Health
- Origin register
- US FDA, United States
- Storage
- Avoid freezing. Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Store ZYCLARA pump bottles upright.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D06BB10 Imiquimod
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 February 2012
- Identifiers
- RxCUI 967017, 967021DailyMed set ID 28cd9b5b-680b-480f-b33d-9c5b52bbf03dNDC 99207-276Application NDA022483
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, pump in 1 carton / 7.5 g in 1 bottle, pump | 99207-276-01 | Bausch Health | 29 February 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Imiquimod
Clinical summary
Imiquimod is a prescription medicine indicated for the topical treatment of clinically typical, visible, or palpable actinic keratoses (AK) of the face or balding scalp in immunocompetent adults, among other approved uses. MedsAcross supplies Imiquimod for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ImiquimodFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Imiquimod prescribing information (Teva Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Aldara: European public assessment report (EPAR) · European Medicines Agency
- Zyclara: European public assessment report (EPAR) · European Medicines Agency
Need Zyclara 0.25% cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.